Medical condition
Pulmonary Hypertension
Pulmonary Hypertension is a medical condition tracked by NovaPharmaNews across 6 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- sildenafil (NOUMED SILDENAFIL) Genito-urinary system and sex hormones (G04)
- riociguat (ADEMPAS) Cardiovascular system (C02)
- treprostinil (TREPROSTINIL SCIPHARM SÀRL) Blood and blood forming organs (B01)
- nitric oxide (INOMAX) Respiratory system (R07)
- iloprost (VENTAVIS) Blood and blood forming organs (B01)
- sitaxentan sodium (THELIN) Cardiovascular system (C02)
Latest Pulmonary Hypertension news
Pulnovo Medical Secures $100 Million Investment from Medtronic for Pulmonary Hypertension Therapies
Pulnovo Medical raises $100M in oversubscribed funding led by Medtronic to advance breakthrough pulmonary hypertension and heart failure treatments.
FDA Approves LungRx Inhaled Therapy: Breakthrough for Pulmonary Hypertension
The FDA has granted approval for LungRx, an inhaled therapy that offers a groundbreaking treatment for pulmonary hypertension, enhancing patient care and outcomes.